Invesco EQQQ NASDAQ-100 UCITS ETF (CHF Hdg) is a equity ETF from Invesco tracking the EQQQ NASDAQ-100 index through physical replication. Domiciled in Ireland and launched in 2017, the fund manages about 807 M € and charges a TER of 0.35% — 35 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Invesco EQQQ NASDAQ-100 UCITS ETF (CHF Hdg) competes with 3 other products on the same index (EQQQ NASDAQ-100): it ranks 3rd by fund size and 3rd by ongoing cost, with a TER of 0.35% against a group median of 0.32%. It has been listed since 2017, 9 years of track record.
On a €10,000 investment the TER costs 35 € a year. The cheapest of the group is Invesco EQQQ NASDAQ-100 UCITS ETF USD at 0.30%, or 30 € on the same amount: a difference of 5 € every year, roughly 50 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 44.9% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in CHF. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 7.6% |
| Apple Inc. | 6.7% |
| Micron Technology Inc | 5.6% |
| Microsoft Corporation | 4.3% |
| Advanced Micro Devices Inc | 4.1% |
| Amazon.com Inc | 4.0% |
| Tesla Inc | 3.3% |
| Alphabet Inc Class A | 3.3% |
| Intel Corporation | 3.0% |
| Alphabet Inc Class C | 3.0% |
| SIX Swiss Exchange | EQCH | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.